Syndax Pharmaceuticals (SNDX) Shares Outstanding (Entity) (2015 - 2026)

Syndax Pharmaceuticals (SNDX) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Syndax Pharmaceuticals 1.77 Bn 1.22 Bn 60.67 Mn 89.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 89.30 Mn
Mar 31, 2026 88.54 Mn
Dec 31, 2025 87.41 Mn
Sep 30, 2025 86.91 Mn
Jun 30, 2025 86.06 Mn
Mar 31, 2025 86.05 Mn
Dec 31, 2024 85.69 Mn
Sep 30, 2024 85.29 Mn
Jun 30, 2024 85.03 Mn
Mar 31, 2024 84.98 Mn
Dec 31, 2023 70.37 Mn
Sep 30, 2023 69.64 Mn
Jun 30, 2023 69.43 Mn
Mar 31, 2023 68.50 Mn
Dec 31, 2022 68.11 Mn
Sep 30, 2022 60.12 Mn
Jun 30, 2022 56.40 Mn
Mar 31, 2022 55.03 Mn
Dec 31, 2021 54.98 Mn
Sep 30, 2021 48.85 Mn